Farydak Approved for Multiple Myeloma

February 24, 2015 4:15 PM

15 0

TUESDAY, Feb. 24, 2015 (HealthDay News) -- Farydak (panobinostat) has been approved by the U.S. Food and Drug Administration to treat multiple myeloma, a cancer of the blood.

Affecting mostly older adults, the disease causes blood plasma cells to multiply rapidly, overtaking other healthy blood cells from the bone marrow. This can weaken the immune system and lead to bone and kidney problems, the FDA said in a news release.

Read more

To category page